GXMC
NKTR icon

Global X Management Company’s Nektar Therapeutics NKTR Stock Holding History

Global X Management Company’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$316K Buy
+431
New +$497K 0.01% 828

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Global X Management Company's NKTR Position: Q2 2018 in Review

Global X Management Company opened a new position in Nektar Therapeutics (NKTR) in Q2 2018: 431 shares worth $316K. The stake represents 0.01% of the portfolio and ranks #828 among its holdings.

378 funds tracked by Wall St. Rank hold NKTR as of Q2 2018.

  • Global X Management Company held 431 shares of Nektar Therapeutics worth $316K as of Q2 2018.
  • Nektar Therapeutics was a new Global X Management Company position in Q2 2018.
  • Nektar Therapeutics made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #828 holding.
  • 378 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.